Yi‐Peng Fu

机构：Obstetrics and Gynecology Hospital of Fudan University · ORCID：0000-0002-4229-6714

发表论文 39 篇 · 总被引 1111 次 · h-index 20

代表论文

• HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1 (2019 · Journal for ImmunoTherapy of Cancer · 被引 126)
• Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer (2020 · Journal for ImmunoTherapy of Cancer · 被引 109)
• Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis (2020 · Cancer Letters · 被引 65)
• New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection (2018 · Journal of Surgical Oncology · 被引 47)
• Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment (2019 · Aging · 被引 41)
• Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection (2017 · The Oncologist · 被引 40)